VAERS reports by lot

GSK Varicella/Shingles lot 592DX: VAERS reports

37 VAERS reports list lot 592DX as a GSK Varicella/Shingles vaccine, received between 2019-09-28 and 2021-12-15. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
37
Reports
5%
Marked serious
0
With a death outcome
9
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction3026%
General / Systemic (non-local)2522%
Dermatological (non-injection-site)1614%
Musculoskeletal1311%
Gastrointestinal109%
Cardiac / Cardiovascular76%
Allergic / Anaphylactic65%
Respiratory43%
Neurological22%
Thrombotic / Hematological11%
Autoimmune / Immune-mediated11%
Psychiatric / Neuropsychiatric11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Pennsylvania6
New York4
California4
Michigan3
Illinois2
Nevada2
Ohio2
Maryland2
Virginia1
Georgia1
New Jersey1
Alabama1

Reports by month received

2019-092
2019-1014
2019-119
2019-123
2020-013
2020-021
2020-043
2021-031
2021-121

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.